Lefkofsky was born in Southfield, Michigan with a simple background and had a childhood much like anyone else. After he graduated from the local high school, Eric went on to attend the University of Michigan and graduated in 1991. Eric Lefkofsky generated a large part of his fortune with his Groupon platform, which helped clients save money when it came to traveling and eating out at restaurants and such. As of late, he is the co-founder of a new company called Tempus along with his longtime friend Brad Keywell. Tempus will focus on genomic sequencing and is intended to greatly help with customizing treatments for cancer.
It made the headlines not too long ago that Eric Lefkosky had amazingly managed to raise a total of $70 million dollars in his latest round of funding for his company, Tempus. This funding, from several Lefkofsky associate investors, combined with previous funding, comes to a grand total of $130 million dollars. All together, that gives this new Chicago based company a net worth of nearly three-quarters of a billion dollars already.
As the CEO of Tempus, Lefkofsky is prepared to invest highly in his new business enterprise, with him and Keywell being the biggest investors so far. Just last year, Lefkofsky let it be known that he was ready to invest a large sum into Tempus to ensure its success, up to $100 million in capital.
Tempus is being created to allow for more precise treatments when it comes to cancer patients by bringing together the vast amounts of health-related data from around the world. Tempus has claimed it will build the largest database of data out there for healthcare for improving on cancer treatments. The company has so far partnered up with several other businesses as well to improve on their compilation of data. According to Lefkofsky, a large amount of the datasets available within healthcare are mostly disorganized and have insufficient data and now for the first time, there is technology available that will bring new possibilities.